1Cardiovascular Research Center, Heshmat Hospital, School of Medicine, Guilan University of Medical Sciences, Rasht, IranAmerican Journal of Cardiovascular Disease Research
, Vol. 1 No. 1
10.12691/ajcdr-1-1-3Copyright © 2013 Science and Education PublishingCite this paper:
Jalal Kheirkhah, Vahid Toulabi, Hassan Moladoust, Mohammad Asadian Rad, Hamid Reza Bonakdar, Anoosh Barzigar, Fardin Mirbolouk, Bijan Shad, Vahid Nikseresht. Cardiac Resynchronization Therapy: Effects on Mitral Regurgitation in Heart Failure Patients. American Journal of Cardiovascular Disease Research
. 2013; 1(1):12-15. doi: 10.12691/ajcdr-1-1-3.
Correspondence to: Hassan Moladoust, Cardiovascular Research Center, Heshmat Hospital, School of Medicine, Guilan University of Medical Sciences, Rasht, Iran. Email: firstname.lastname@example.org
Background: Cardiac resynchronization therapy (CRT) has been introduced as a promising therapeutic choice in heart failure patients (HF) with ventricular dyssynchrony, shown with a wide QRS. Objective: This study aimed to evaluate the effect of CRT on the severity of mitral regurgitation (MR) quantitatively using the volumetric Doppler method in HF patients. Patients and methods: This was a prospective before-after survey in which 22 HF patients with wide QRS (≥120 ms) and NYHA class III who were included. All patients were evaluated initially for QRS width, NYHA class, MR volume, MR fraction HF and mitral valve area (MV area). Biventricular pacing was done through cardiac-resynchronization device along with three pacing leads and same evaluations were done after CRT. Results: The mean (SD) QRS width and NYHA class were significantly decreased after CRT in HF patients (P<0.001). Also MR volume (46.9±30.2cc vs. 27.0±26.4cc, P<0.001) and fraction (40.1±25.5% vs. 26.8±22.7%, P=0.002) were improved following CRT. The decrease of MV area after CRT was also significant (10.6±3.0cm2 vs. 8.6±2.6cm2, P<0.001). Conclusion: As MR is associated with morbidity and mortality in HF patients and the standard surgical therapy may not be practical for a majority of them, this novel treatment may improve their disease condition significantly.